دورية أكاديمية

Minocycline enhances the mesenchymal stromal/stem cell pro-healing phenotype in triple antimicrobial-loaded hydrogels.

التفاصيل البيبلوغرافية
العنوان: Minocycline enhances the mesenchymal stromal/stem cell pro-healing phenotype in triple antimicrobial-loaded hydrogels.
المؤلفون: Guerra AD; School of Pharmacy, Division of Pharmaceutical Sciences, Pharmacy Practice Division, University of Wisconsin-Madison, 777 Highland Avenue, Madison, WI 53705, USA. Electronic address: aguerra@wisc.edu., Rose WE; School of Pharmacy, Division of Pharmaceutical Sciences, Pharmacy Practice Division, University of Wisconsin-Madison, 777 Highland Avenue, Madison, WI 53705, USA. Electronic address: warren.rose@wisc.edu., Hematti P; School of Medicine and Public Health, Department of Medicine, Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, 1685 Highland Avenue, Madison, WI 53705, USA. Electronic address: pxh@medicine.wisc.edu., Kao WJ; School of Pharmacy, Division of Pharmaceutical Sciences, Pharmacy Practice Division, University of Wisconsin-Madison, 777 Highland Avenue, Madison, WI 53705, USA; College of Engineering, Department of Biomedical Engineering, University of Wisconsin-Madison, 1415 Engineering Drive, Madison, WI 53706, USA; School of Medicine and Public Health, Department of Surgery, University of Wisconsin-Madison, 1685 Highland Avenue, Madison, WI 53705, USA. Electronic address: WJKao@wisc.edu.
المصدر: Acta biomaterialia [Acta Biomater] 2017 Mar 15; Vol. 51, pp. 184-196. Date of Electronic Publication: 2017 Jan 07.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7568 (Electronic) Linking ISSN: 17427061 NLM ISO Abbreviation: Acta Biomater Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Kidlington, Oxford, UK : Elsevier, c2004-
مواضيع طبية MeSH: Anti-Infective Agents/*pharmacology , Hydrogels/*pharmacology , Mesenchymal Stem Cells/*cytology , Minocycline/*pharmacology , Wound Healing/*drug effects, Adult ; Bacterial Adhesion/drug effects ; Cell Adhesion/drug effects ; Cell Survival/drug effects ; Human Umbilical Vein Endothelial Cells/drug effects ; Humans ; Immunomodulation/drug effects ; Intercellular Signaling Peptides and Proteins/pharmacology ; Mesenchymal Stem Cells/drug effects ; Microbial Sensitivity Tests ; Neovascularization, Physiologic/drug effects ; Phenotype ; Staphylococcus aureus/drug effects ; Staphylococcus aureus/growth & development
مستخلص: Mesenchymal stromal/stem cells (MSCs) have demonstrated pro-healing properties including an anti-inflammatory cytokine profile and the promotion of angiogenesis via expression of growth factors in pre-clinical models. MSCs encapsulated in poly(ethylene glycol) diacrylate (PEGdA) and thiolated gelatin poly(ethylene glycol) (Gel-PEG-Cys) crosslinked hydrogels have led to controlled cellular presentation at wound sites with favorable wound healing outcomes. However, the therapeutic potential of MSC-loaded hydrogels may be limited by non-specific protein adsorption on the delivery matrix that could facilitate the initial adhesion of microorganisms and subsequent virulent biofilm formation. Antimicrobials loaded concurrently in the hydrogels with MSCs could reduce microbial bioburden and promote healing, but the antimicrobial effect on the MSC wound healing capacity and the antibacterial efficacy of the hydrogels is unknown. We demonstrate that minocycline specifically induces a favorable change in MSC migration capacity, proliferation, gene expression, extracellular matrix (ECM) attachment, and adhesion molecule and growth factor release with subsequent increased angiogenesis. We then demonstrate that hydrogels loaded with MSCs, minocycline, vancomycin, and linezolid can significantly decrease bacterial bioburden. Our study suggests that minocycline can serve as a dual mechanism for the regenerative capacity of MSCs and the reduction of bioburden in triple antimicrobial-loaded hydrogels.
Statement of Significance: Wound healing is a complex biological process that can be hindered by bacterial infection, excessive inflammation, and inadequate microvasculature. In this study, we develop a new formulation of poly(ethylene glycol) diacrylate and thiolated gelatin poly(ethylene glycol) crosslinked hydrogels loaded with minocycline, vancomycin, linezolid, and mesenchymal stromal/stem cells that induces a favorable wound healing phenotype in mesenchymal stromal/stem cells and prevents bacterial bioburden on the hydrogel. This combinatorial approach to biomaterial development has the potential to impact wound healing for contaminated full thickness cutaneous wounds.
(Copyright © 2017. Published by Elsevier Ltd.)
References: Acta Biomater. 2012 Jul;8(7):2504-16. (PMID: 22484717)
J Pathol. 2004 Jul;203(3):831-8. (PMID: 15221943)
Antimicrob Agents Chemother. 1974 Dec;6(6):722-8. (PMID: 4451345)
J Clin Invest. 2005 Nov;115(11):3117-27. (PMID: 16276417)
PLoS One. 2015 Sep 25;10(9):e0137419. (PMID: 26406476)
Biomaterials. 2011 Oct;32(28):6692-709. (PMID: 21715002)
Innovations (Phila). 2013 Nov-Dec;8(6):433-9. (PMID: 24225815)
Stem Cell Res Ther. 2015 Mar 24;6:44. (PMID: 25888925)
Wound Repair Regen. 2010 Nov-Dec;18(6):655-61. (PMID: 20955344)
Gene. 2012 Apr 15;497(2):131-9. (PMID: 22523757)
Biomaterials. 2012 Jan;33(1):48-58. (PMID: 21955690)
J Burn Care Res. 2009 Jan-Feb;30(1):98-104. (PMID: 19060724)
J Biol Chem. 2011 Jul 15;286(28):25007-15. (PMID: 21592963)
Expert Opin Drug Deliv. 2010 Apr;7(4):429-44. (PMID: 20331353)
Clin Exp Allergy. 2011 Apr;41(4):526-34. (PMID: 21255158)
Biomaterials. 2012 Sep;33(26):5967-82. (PMID: 22695065)
Tissue Eng. 2005 May-Jun;11(5-6):896-903. (PMID: 15998229)
Tissue Eng. 2003 Feb;9(1):95-103. (PMID: 12625958)
Biomaterials. 2012 Oct;33(28):6783-92. (PMID: 22784602)
PLoS One. 2011;6(7):e21888. (PMID: 21779348)
Trends Genet. 2013 Oct;29(10):569-74. (PMID: 23810203)
J Biosci Bioeng. 2016 Feb;121(2):213-9. (PMID: 26315505)
J Biomed Mater Res A. 2003 Oct 1;67(1):224-34. (PMID: 14517880)
Front Physiol. 2015 Sep 30;6:262. (PMID: 26483695)
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3806-11. (PMID: 19234121)
J Signal Transduct. 2014;2014:173026. (PMID: 25371820)
J Pathol. 2009 Jan;217(2):318-24. (PMID: 19023885)
BMC Microbiol. 2015 Mar 28;15:75. (PMID: 25886581)
Appl Environ Microbiol. 2005 May;71(5):2663-76. (PMID: 15870358)
Beilstein J Nanotechnol. 2014 Nov 10;5:2058-69. (PMID: 25551033)
Wounds. 2015 May;27(5):134-40. (PMID: 25965183)
Am J Physiol Regul Integr Comp Physiol. 2006 Oct;291(4):R880-4. (PMID: 16728464)
Acta Biomater. 2013 Nov;9(11):8802-14. (PMID: 23811217)
Am J Respir Cell Mol Biol. 2009 Jun;40(6):643-53. (PMID: 18988920)
Ann Surg. 2012 Aug;256(2):371-7. (PMID: 22609841)
Blood. 1999 Mar 1;93(5):1579-85. (PMID: 10029586)
Exp Hematol. 2008 Mar;36(3):350-9. (PMID: 18179856)
Biomaterials. 2013 Oct;34(32):7840-50. (PMID: 23891515)
Int Braz J Urol. 2015 Sep-Oct;41(5):990-1001. (PMID: 26689526)
Int J Artif Organs. 2008 Sep;31(9):761-70. (PMID: 18924087)
J Biomed Mater Res A. 2016 May;104(5):1202-11. (PMID: 26780154)
Annu Rev Pathol. 2011;6:457-78. (PMID: 21073342)
J Cell Biochem. 2016 Sep;117(9):2128-37. (PMID: 26888666)
Expert Rev Anti Infect Ther. 2015 May;13(5):605-13. (PMID: 25746414)
Curr Med Chem. 2011;18(14):2129-45. (PMID: 21517762)
J Dairy Sci. 2012 Apr;95(4):1913-20. (PMID: 22459838)
Clin Orthop Relat Res. 2013 Jan;471(1):250-7. (PMID: 22552768)
Exp Dermatol. 2013 May;22(5):307-10. (PMID: 23614735)
Mol Pharmacol. 2008 May;73(5):1578-86. (PMID: 18314496)
Biochem J. 1994 Sep 1;302 ( Pt 2):331-3. (PMID: 8092983)
Anal Biochem. 2015 Sep 1;484:1-3. (PMID: 25963891)
Stem Cell Rev. 2014 Jun;10(3):417-28. (PMID: 24500853)
Circ Res. 2009 Oct 9;105(8):818-26. (PMID: 19729595)
Cytotherapy. 2014 Nov;16(11):1476-1485. (PMID: 24950679)
Biores Open Access. 2016 Jan 01;5(1):37-48. (PMID: 26862471)
PLoS One. 2010 Dec 07;5(12):e14247. (PMID: 21151872)
Cytotherapy. 2006;8(4):315-7. (PMID: 16923606)
J Food Prot. 2012 Feb;75(2):238-44. (PMID: 22289583)
Stem Cells Dev. 2007 Jun;16(3):489-502. (PMID: 17610379)
J Biomater Sci Polym Ed. 2012;23 (12 ):1595-611. (PMID: 21801489)
Int J Pharm. 2015 Jul 25;490(1-2):32-8. (PMID: 25934427)
AAPS J. 2015 May;17(3):620-30. (PMID: 25716147)
Cell Stem Cell. 2008 Feb 7;2(2):141-50. (PMID: 18371435)
Wound Repair Regen. 2008 Jan-Feb;16(1):37-44. (PMID: 18086294)
J Innate Immun. 2010;2(6):560-75. (PMID: 20587998)
Biores Open Access. 2015 Jan 01;4(1):75-88. (PMID: 26309784)
J Cell Biol. 2001 Nov 12;155(4):637-48. (PMID: 11696559)
JAMA. 2014 Oct 15;312(15):1552-64. (PMID: 25321910)
ACS Appl Mater Interfaces. 2016 Mar;8(12 ):7691-708. (PMID: 26958867)
Antimicrob Agents Chemother. 2008 Oct;52(10):3550-7. (PMID: 18663023)
Blood. 2008 May 1;111(9):4551-8. (PMID: 18256324)
Antimicrob Agents Chemother. 2003 Dec;47(12):3675-81. (PMID: 14638464)
Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):699-710. (PMID: 20138940)
PLoS One. 2013;8(2):e56971. (PMID: 23451124)
Cell Res. 2010 May;20(5):510-8. (PMID: 20368733)
J Immunol. 2010 Mar 1;184(5):2321-8. (PMID: 20130212)
Stem Cells Transl Med. 2012 Oct;1(10):740-9. (PMID: 23197666)
Sci Transl Med. 2012 Sep 26;4(153):153rv10. (PMID: 23019658)
Nutr Res Pract. 2013 Feb;7(1):9-14. (PMID: 23422838)
Antimicrob Agents Chemother. 2012 Jan;56(1):140-7. (PMID: 22064533)
Biomed Pharmacother. 2016 Mar;78:156-64. (PMID: 26898437)
Biol Pharm Bull. 2014;37(4):679-82. (PMID: 24694615)
J Mol Microbiol Biotechnol. 2004;8(4):232-42. (PMID: 16179800)
معلومات مُعتمدة: P30 CA014520 United States CA NCI NIH HHS; R21 HL115482 United States HL NHLBI NIH HHS; T32 GM008349 United States GM NIGMS NIH HHS
فهرسة مساهمة: Keywords: Hydrogel; Mesenchymal stromal/stem cells; Minocycline; Staphylococcus aureus; Wound healing
المشرفين على المادة: 0 (Anti-Infective Agents)
0 (Hydrogels)
0 (Intercellular Signaling Peptides and Proteins)
FYY3R43WGO (Minocycline)
تواريخ الأحداث: Date Created: 20170111 Date Completed: 20171106 Latest Revision: 20240610
رمز التحديث: 20240610
مُعرف محوري في PubMed: PMC5704963
DOI: 10.1016/j.actbio.2017.01.021
PMID: 28069512
قاعدة البيانات: MEDLINE
الوصف
تدمد:1878-7568
DOI:10.1016/j.actbio.2017.01.021